About Us >> Advisory Board

»

Clinical & Scientific Advisory Board

Michael Camilleri, M.D., Ph. D.

Professor of Physiology and Medicine at the Mayo Clinic, Minnesota

Dr. Michael Camilleri is a Professor of Physiology and Medicine at the Mayo Clinic, Minnesota, MN.  He has contributed extensively to the fields of enteric neurosciences, motility, and inflammatory bowel diseases (IBD).  Dr. Camilleri is on the editorial boards of a number of prestigious journals including Neurogastroenterology and Motility and American Neurogastroenterology. He has been President Elect of the American Neurogastroenterology and Motility Society 2007.

Lin Chang, M.D.

Professor of Medicine, David Geffen School of Medicine, UCLA

Dr. Lin Chang is a Professor of Medicine in the Division of Digestive Diseases and Department of Medicine at the David Geffen School of Medicine at UCLA. She is the Co-Director and Head of the Clinical Program at the Center for Neurovisceral Sciences & Women's Health and Director of the Women's Digestive Health Center at UCLA. Dr. Chang is the Co-chair of the Rome III subcommittee on Gender, Age and Cultural Influences on Functional Bowel Disorders. She is currently serving on the FDA GI Advisory Committee.

Dennis Riff, M.D.

Medical Director for the Advanced Clinical Research Institute in Anaheim

Dr. Dennis Riff is board -certified in gastroenterology and internal medicine. He currently serves as the Medical Director for the Advanced Clinical Research Institute in Anaheim, CA. Dr. Riff has contributed significantly to the medical literature in gastrointestinal disorders and has been the principal investigator on numerous gastrointestinal-related clinical trials.

About UsAbout_Synergy_Pharmaceuticals.htmlshapeimage_9_link_0
PipelinePipeline_Overview.htmlshapeimage_10_link_0
PartneringPartnering.htmlshapeimage_11_link_0
Investor RelationsInvestor_Relations_Information.htmlshapeimage_12_link_0
NewsSynergy_News_Summary.htmlshapeimage_13_link_0
Contact UsContact_Us.htmlshapeimage_14_link_0
About UsAbout_Synergy_Pharmaceuticals.htmlshapeimage_16_link_0
ManagementSynergy_Management_Team.htmlshapeimage_17_link_0
Board of DirectorsSynergy_Board_of_Directors.htmlshapeimage_18_link_0
Clinical & Scientific Advisory Boardshapeimage_19_link_0
 Legal    |   Contact UsLegal.htmlContact_Us.htmlshapeimage_21_link_0shapeimage_21_link_1
Copyright 2010 © Synergy Pharmaceuticals, Inc., 420 Lexington Avenue, Suite 1609, New York, NY 10170, USA

Douglas Drossman, M.D.

Professor of Medicine and Psychiatry, UNC School of Medicine

Dr. Douglas Drossman is a Professor of Medicine and Psychiatry, UNC School of Medicine, Division of Gastroenterology & Hepatology, and Co-Director of the UNC Center for Functional GI & Motility Disorders. He is President of the Rome Foundation and Scientific Director and member of the Board of the International Foundation for Functional GI Disorders (IFFGD). He has published extensively in the field of gastroenterology, including the textbook Functional GI Disorders (Rome I, Rome II and Rome III)

Careers at SynergyCareers_at_Synergy_Pharmaceuticals.htmlshapeimage_24_link_0

Scott Plevy, M.D.

Associate Professor of Medicine, Microbiology and Immunology, UNC School of Medicine

Dr. Scott Plevy is an Associate Professor of Medicine, Microbiology and Immunology at the University of North Carolina School of Medicine, Division of Gastroenterology & Hepatology.  He is the Core Director of the Immunotechnology Core in the Center for Gastrointestinal Biology and Disease as well as the Director of the University of North Carolina Federation of Clinical Immunology Societies. Dr. Plevy has contributed significantly to the medical literature on Crohn’s disease and ulcerative colitis, and has been the principal investigator on numerous ulcerative colitis and Crohn’s disease clinical trials.